FDA approves Aerie glaucoma therapy Rocklatan

Aerie said late Tuesday FDA approved Rocklatan netarsudil/latanoprost to reduce intraocular pressure in patients with open-angle

Read the full 166 word article

How to gain access

Continue reading with a
two-week free trial.